NCT00468312View on ClinicalTrials.gov

Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Treatment of Seasonal Allergic Rhinitis (Study P05106)(COMPLETED)

PHASE3CompletedINTERVENTIONAL

Enrollment

429

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG

Mometasone furoate nasal spray

Two sprays (50 mcg/spray) in each nostril (200 mcg daily) in the morning

DRUG

Placebo

Two sprays in each nostril in the morning

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00468312 - Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Treatment of Seasonal Allergic Rhinitis (Study P05106)(COMPLETED) | Biotech Hunter | Biotech Hunter